Poniard Pharmaceuticals, Inc.
PARD
$0.0001
$0.000.00%
OTC PK
| 09/30/2011 | 06/30/2011 | 03/31/2011 | 12/31/2010 | 09/30/2010 | |
|---|---|---|---|---|---|
| Net Income | -3.77M | -3.86M | -3.25M | -5.17M | -6.45M |
| Total Depreciation and Amortization | 311.00K | 317.00K | 323.00K | 324.00K | 327.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | 256.00K | 243.00K |
| Total Other Non-Cash Items | 810.00K | 873.00K | 1.03M | 2.12M | 1.34M |
| Change in Net Operating Assets | 942.00K | 986.00K | -130.00K | -2.58M | 673.00K |
| Cash from Operations | -1.71M | -1.68M | -2.02M | -5.05M | -3.87M |
| Capital Expenditure | 0.00 | -2.00K | -7.00K | 0.00 | -7.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 16.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 0.00 | 3.03M | 9.21M | 6.65M |
| Cash from Investing | 0.00 | -2.00K | 3.03M | 9.21M | 6.66M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -13.80M | -1.97M |
| Issuance of Common Stock | 0.00 | 0.00 | 3.18M | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.00 | -96.00K | -- | -96.00K | 0.00 |
| Other Financing Activities | -- | -- | -- | 0.00 | 0.00 |
| Cash from Financing | 0.00 | -96.00K | 3.18M | -13.90M | -1.97M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.71M | -1.78M | 4.19M | -9.73M | 817.00K |